Related Experiment Video
Updated: Apr 16, 2026
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Preclinical Models of Encephalopathy of Prematurity
Lauren L Jantzie1, Shenandoah Robinson
1Department of Pediatrics, University of New Mexico, Albuquerque, N. Mex., USA.
Insights
Encephalopathy of prematurity (EoP) causes CNS abnormalities in preterm infants. Current animal models incompletely mimic human EoP, hindering diagnosis and treatment development for these neurological deficits.
Area of Science:
- Neuroscience
- Developmental Biology
- Pediatric Neurology
Background:
- Encephalopathy of prematurity (EoP) involves CNS abnormalities from preterm birth.
- Limited understanding of how early birth injury causes neurological deficits in preterm children.
- Current knowledge gaps hinder real-time diagnosis and effective intervention development.
Purpose of the Study:
- To review preclinical models for studying EoP.
- To identify knowledge gaps in EoP pathophysiology and evolution.
- To discuss challenges in developing clinically relevant EoP models.
Main Methods:
- Review of existing preclinical animal models for EoP.
- Analysis of model limitations in recapitulating human EoP.
- Discussion of optimizing models for studying injury timing, type, and severity.
Main Results:
- Preclinical models partially replicate EoP's molecular, cellular, and functional aspects.
- Inflammation-based models (hypoxic-ischemic, infectious) in mammals show clinical relevance.
- Functional assays should assess gait, seizure, and cognitive/behavioral deficits.
Conclusions:
- No single model perfectly captures EoP; multiple models offer broader insights.
- Optimizing injury parameters and functional assays is crucial for translational research.
- Integrated use of diverse models is key to timely diagnosis and tailored neurointerventions for preterm infants.
Abstract:
Encephalopathy of prematurity (EoP) encompasses the central nervous system (CNS) abnormalities associated with injury from preterm birth. Although rapid progress is being made, limited understanding exists of how cellular and molecular CNS injury from early birth manifests as the myriad of neurological deficits in children who are born preterm. More importantly, this lack of direct insight into the pathogenesis of these deficits hinders both our ability to diagnose those infants who are at risk in real time and could potentially benefit from treatment and our ability to develop more effective interventions. Current barriers to clarifying the pathophysiology, developmental trajectory, injury timing, and evolution include preclinical animal models that only partially recapitulate the molecular, cellular, histological, and functional abnormalities observed in the mature CNS following EoP. Inflammation from hypoxic-ischemic and/or infectious injury induced in utero in lower mammals, or actual prenatal delivery of more phylogenetically advanced mammals, are likely to be the most clinically relevant EOP models, facilitating translation to benefit infants. Injury timing, type, severity, and pathophysiology need to be optimized to address the specific hypothesis being tested. Functional assays of the mature animal following perinatal injury to mimic EoP should ideally test for the array of neurological deficits commonly observed in preterm infants, including gait, seizure threshold and cognitive and behavioral abnormalities. Here, we review the merits of various preclinical models, identify gaps in knowledge that warrant further study and consider challenges that animal researchers may face in embarking on these studies. While no one model system is perfect, insights relevant to the clinical problem can be gained with interpretation of experimental results within the context of inherent limitations of the chosen model system. Collectively, optimal use of multiple models will address a major challenge facing the field today - to identify the type and severity of CNS injury these vulnerable infants suffer in a safe and timely manner, such that emerging neurointerventions can be tailored to specifically address individual reparative needs.
